Skip to content
Tuesday, August 11, 2026
Never miss a recall or a rule change
Go Pro · $20/mo →
Inside MedSpa
Menu
FDA Recall & Compliance Alerts for Medspa Owners
Inside MedSpa
Latest
Topics
Market
Regulatory
Business & M&A
Devices & Tech
Compliance
Injectables
Search Demand
Marketing
Growth & Revenue
Operations
Trends & Forecast
Starting a Med Spa
All Articles
Briefings & Roundups
Tools
Calculators
Treatment Comparisons
Ingredient Glossary
Recalls & Approvals
Safety Signals
50-State Law Tracker
Stock & M&A Watch
Resources
Resource Library
Templates & Checklists
Guides & Deep-Dives
Compliance Cheat-Sheet
Pricing
Sign in
Subscribe →
Market
South Korea's Big Three Post ₩225.9B Q2 Revenue
today
Market
Daewoong's NABOTA Enters Seventh Middle East Market
2 days ago
Regulatory
Botox Masseter Indication Moves Closer to FDA OK
today
Regulatory
FDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear
2 days ago
Business & M&A
Indonesia Opens First Botulinum Toxin Plant
today
Devices & Tech
InMode Q2 Beats EPS Forecast, Revenue Tops Estimates
2 days ago
Business & M&A
Galderma Raises 2026 Guidance After Robust H1
today
Business & M&A
Evolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance
2 days ago
Business & M&A
Evolus Posts Third Straight Profitable Quarter
yesterday
Regulatory
FDA Accepts BOTOX Cosmetic sBLA for Masseter Prominence
yesterday
Business & M&A
Evolus Q2 Revenue Surges 21%, Adjusted EBITDA Swings Positive
yesterday
Business & M&A
Perceptive Advisors Takes New Stake in Evolus
yesterday
Market
South Korea's Big Three Post ₩225.9B Q2 Revenue
today
Market
Daewoong's NABOTA Enters Seventh Middle East Market
2 days ago
Regulatory
Botox Masseter Indication Moves Closer to FDA OK
today
Regulatory
FDA Accepts BOTOX Masseter sBLA—Jawline Approval Path Clear
2 days ago
Business & M&A
Indonesia Opens First Botulinum Toxin Plant
today
Devices & Tech
InMode Q2 Beats EPS Forecast, Revenue Tops Estimates
2 days ago
Business & M&A
Galderma Raises 2026 Guidance After Robust H1
today
Business & M&A
Evolus Q2 Revenue Hits $84.1M, Raises 2026 Guidance
2 days ago
Business & M&A
Evolus Posts Third Straight Profitable Quarter
yesterday
Regulatory
FDA Accepts BOTOX Cosmetic sBLA for Masseter Prominence
yesterday
Business & M&A
Evolus Q2 Revenue Surges 21%, Adjusted EBITDA Swings Positive
yesterday
Business & M&A
Perceptive Advisors Takes New Stake in Evolus
yesterday
Search
Find anything in Inside MedSpa.
Search Inside MedSpa
Try:
Trends
·
Rule changes
·
Calculators
·
News
·
Guides
The twice-a-week intelligence brief
Go Pro · $20/mo
→